New Results
Heterogeneity in the tumour size dynamics differentiates Vemurafenib, Dabrafenib and Trametinib in metastatic melanoma
Hitesh B. Mistry, David Orrell, Raluca Eftimie
doi: https://doi.org/10.1101/103366
Hitesh B. Mistry
1Centre for Drug Disease Modelling and Simulation, Manchester Pharmacy School, University of Manchester, Oxford Road, M13 9PL, UK
David Orrell
2Systems Forecasting, 330 Spadina Road, Toronto ON, Canada M5R 2V9
Raluca Eftimie
3Department of Mathematics, University of Dundee, Dundee, DD1 4HN, UK
Article usage
Posted May 17, 2017.
Heterogeneity in the tumour size dynamics differentiates Vemurafenib, Dabrafenib and Trametinib in metastatic melanoma
Hitesh B. Mistry, David Orrell, Raluca Eftimie
bioRxiv 103366; doi: https://doi.org/10.1101/103366
Subject Area
Subject Areas
- Biochemistry (11760)
- Bioengineering (8762)
- Bioinformatics (29230)
- Biophysics (14991)
- Cancer Biology (12118)
- Cell Biology (17424)
- Clinical Trials (138)
- Developmental Biology (9432)
- Ecology (14190)
- Epidemiology (2067)
- Evolutionary Biology (18319)
- Genetics (12254)
- Genomics (16809)
- Immunology (11877)
- Microbiology (28110)
- Molecular Biology (11609)
- Neuroscience (61037)
- Paleontology (452)
- Pathology (1873)
- Pharmacology and Toxicology (3239)
- Physiology (4967)
- Plant Biology (10431)
- Synthetic Biology (2888)
- Systems Biology (7346)
- Zoology (1653)